Bellevue Asset Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Bellevue Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$7.7 - $37.13 $377 - $1,819	-49 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$32.73 - $47.95 $229 - $335	-7 Reduced 12.5%	49 $2,000
Q1 2021 May 12, 2021	SELL	$40.39 - $56.73 $80 - $113	-2 Reduced 3.45%	56 $3,000
Q4 2020 Feb 11, 2021	SELL	$51.77 - $66.18 $465 - $595	-9 Reduced 13.43%	58 $3,000
Q1 2020 May 13, 2020	BUY	$33.63 - $69.4 $1,345 - $2,776	40 Added 148.15%	67 $3,000
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $855 - $1,888	27 New	27 $2,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.